SIRT6 and familial pancreatic carcinoma: Consequently, SIRT6’s multifaceted role in promoting the synthesis of Ca2+ mobilizing second messengers and regulating Ca2+-dependent transcription factors underscores its potential use as a therapeutic target to mitigate cancer-induced inflammation, angiogenesis and metastasis in pancreatic cancer.